The New Jersey Cannabis Regulatory Commission (NJ-CRC) has issued “Guidance on Workplace Impairment” for employers in the Garden State which explained that “an employee shall not be subject to any adverse action by an employer solely due to the presence of cannabinoid metabolites in the employee’s bodily fluid” found during a marijuana drug test.
Issued on September 9, 2022, the guidance stated that a failed marijuana drug test alone is insufficient to support an adverse action but that “such a test combined with evidence-based documentation of physical signs or other evidence of impairment during an employee’s prescribed work hours may be sufficient to support an adverse employment action.”
Since marijuana can remain in users long after usage, the NJ-CRC – which establishes and enforces rules and regulations governing cannabis in the state – suggested that employers should “establish evidence-based protocols for documenting observed behavior and physical signs of impairment to develop reasonable suspicion, and then to utilize a drug test.”
Employers can designate a staff member to assist with making determinations of suspected marijuana use during work who is sufficiently trained to determine impairment and qualified to complete a “Reasonable Suspicion Observation Report” documenting the behavior, physical signs, and evidence supporting suspected marijuana use or impairment during work.
Employers still have the right to maintain a drug free workplace and may require an employee to undergo a drug test upon reasonable suspicion of an employee’s use of marijuana while at work, after finding any observable signs of impairment related to the use of marijuana, or following a work-related accident. The guidance from the NJ-CRC is available here.
The guidance is a first step toward formulating and approving standards for “Workplace Impairment Recognition Expert (WIRE)” certifications to be issued to employees or contractors to perform services based on education and training in detecting and identifying an employee’s usage of, or impairment from, marijuana. New Jersey legalized recreational marijuana use in 2021.
“Striking a balance between workplace safety and work performance and adult employees’ right to privacy and to consume cannabis during their off hours is possible,” NJ-CRC Executive Director Jeff Brown stated in a news story about the guidance posted on the official State of New Jersey website. “We have been doing that with alcohol without thought.”
ClearStar is a leading Human Resources technology company specializing in background checks, drug tests, clinical testing, and occupational health screening. ClearStar offers drug testing that is fully integrated with major laboratories with a single candidate invite for all services via email or text. For more information about drug testing, contact ClearStar.
On September 21, 2022, ClearStar will sponsor a free webinar titled “Continuing the Discussion: A Deep Dive Into 5 More States’ Drug Testing Laws” hosted by Bill Current, President and Founding Partner of the Current Consulting Group, LLC (CCG), and CCG Senior Legal Consultant Yvette Farnsworth Baker, Esq. To register for the free webinar, click here.
© 2022 ClearStar. All rights reserved. – Making copies of or using any part of the ClearStar website for any purpose is prohibited unless written authorization is first obtained from ClearStar. ClearStar does not provide or offer legal services or legal advice of any kind or nature. Any information on this website is for educational purposes only.